Patents
Patents for C07K 19 - Hybrid peptides (29,428)
08/2006
08/02/2006CN1813000A Synthetic antibody phage libraries
08/02/2006CN1810839A Anti-hepatitis B virus fusion protein and its coding gene and application
08/02/2006CN1810838A Recombinant antigen protein for diagnosing ox tuberculosis and its prepn process
08/02/2006CN1810836A Human proinsulin-KGD chimeric peptide as new recombinat antithrombotic with thrombocyte GP-IIb-IIIa receptor specificity
08/02/2006CN1810832A Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
08/02/2006CN1810830A HIV-1 yesisting polypeptide C22, its coding sequence and prepn process
08/02/2006CN1267555C Sea anemone neurotoxin gene Sr4 and application thereof
08/02/2006CN1267554C Sea anemone neurotoxin gene Sr5 and application thereof
08/02/2006CN1267453C Human erythropoietin Fc fusion protein with raised bioactivity
08/01/2006US7084262 Analysis and separation of platelet-derived growth factor proteins
08/01/2006US7083957 Modified proteins, designer toxins, and methods of making thereof
08/01/2006US7083943 Polynucleotides related to murine anti-idiotype antibody 11D10 and methods of use thereof
08/01/2006US7083796 Fusion proteins of mycobacterium tuberculosis
08/01/2006US7083793 Coding Mycobacterium tuberculosis; isolation protein
08/01/2006US7083785 Tumor necrosis factor family and its blocking agent
08/01/2006US7083784 Molecules with extended half-lives, compositions and uses thereof
07/2006
07/27/2006WO2006077146A2 Method for producing albumin conjugates containing gyrase inhibitors
07/27/2006WO2005111078A3 Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept
07/27/2006WO2005102038A3 Expression of polypeptides in rod outer segment membranes
07/27/2006WO2003085086A3 Motif-grafted hybrid polypeptides and uses thereof
07/27/2006US20060168672 B7-like molecules and uses thereof
07/27/2006US20060167225 Novel fluorescent protein from aequorea coerulscens and methods for using the same
07/27/2006US20060166889 Chimeric peptides that facilitate the transport of insulin across biological membranes that have a first domain having a specific translocation sequence and a second domain having at least a biologically active portion of an insulin polypeptide; treatment of diabetes
07/27/2006US20060166274 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
07/27/2006US20060166194 Diagnosis and treatment of cancer
07/27/2006US20060166186 Detecting a compartment or a macromolecule of a cell by expressing a polynucleotide encoding chimeric polypeptide in the cell having single chain Fv region that binds a detectable molecule and a S-AKAP84 region that binds the macromolecule or targets the compartment; exposing cell to molecule; analyzing
07/27/2006US20060165634 Advanced cell-transducing transport domain-target protein-transport domain fusion protein and uses thereof
07/27/2006DE102005002991A1 Verfahren zur Herstellung von Albumin-Konjugaten mit Gyrasehemmern Process for the preparation of conjugates with albumin gyrase inhibitors
07/27/2006DE102005002353A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications
07/26/2006EP1683867A1 Groups of Borrelia burgdorferi and Borrelia afzelii that cause lyme disease in humans
07/26/2006EP1683811A2 Compositions and methods for the treatment of tumors
07/26/2006EP1683808A1 Means and methods for breaking noncovalent binding interactions between molecules
07/26/2006EP1682584A1 A pharmaceutical composition comprising an immunoglobulin fc region as a carrier
07/26/2006EP1682583A1 Protein complex using immunoglobulin fragment and method for the preparation thereof
07/26/2006EP1682582A1 Method for the mass production of immunoglobulin constant region
07/26/2006EP1682581A1 Igg fc fragment for a drug carrier and method for the preparation thereof
07/26/2006EP1682164A2 Cytokine antagonist molecules
07/26/2006EP1481065B1 Method for detection of leptin receptor ligands
07/26/2006CN1807645A Fusion gene of nisin and bee peptide and its construct method and uses
07/26/2006CN1807460A Recombinant fusion protein of fibroin and RGD, and its biological synthesis method
07/26/2006CN1807459A Activated collagen protein stent material and its special restoration factor for binding
07/26/2006CN1807458A Activated collagen bone restoration material and its special bone restoration factor for bone binding
07/26/2006CN1807457A Fusion protein of immune globulin binding structural domain and fluorescence protein and its uses
07/26/2006CN1807456A Recombinant human parathormone PTH1-34 preparation method
07/26/2006CN1807450A SIP gene and its coded protein and uses
07/25/2006US7081443 A fusion proteins comprising a cyclic peptide linked to a receptor as a cell growth factors, promoting cell proliferation, cell antiproliferative agents; soluble, potent
07/25/2006US7081354 Interleukin and albumin fusion protein
07/20/2006WO2006012416A3 Specific inhibition of autoimmunity and diseases associated with autoantigens
07/20/2006WO2005085430A3 Adzymes and uses thereof
07/20/2006US20060160146 Method of screening compound affecting amyloid beta production
07/20/2006US20060159700 Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation
07/20/2006US20060159682 Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof
07/20/2006CA2593697A1 Pan-her antagonists and methods of use
07/19/2006EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
07/19/2006EP1681304A2 Recombinant fusion proteins of growth hormone and serum albumin
07/19/2006EP1681299A2 Methods for purifying highly anionic proteins
07/19/2006EP1681298A2 Methods for purifying highly anionic proteins
07/19/2006EP1404428B1 Methods for purifying highly anionic proteins
07/19/2006EP1075492B1 Melanocortin 1 receptor selective compounds
07/19/2006CN1803846A Hybrid protein of p53 protein epitope(SQAMDDLMLS) and filobactivirus gene 8 protein and application thereof
07/19/2006CN1264862C Diphtherin-gonadoliberin chimeric protein
07/19/2006CN1264861C Receptor targeting chimeric toxin with junctional sequence
07/19/2006CN1264572C Fusion protein for treating HBV and its uses
07/18/2006US7078380 comprises vancomycin-type antibiotics; peptide antibiotics; membrane proteins; defensins; for inhibiting peptidoglycan biosynthesis
07/18/2006US7078193 Pathogenic Escherichia coli associated protein espA
07/18/2006CA2194135C Recombinant mono and poly antigens to detect cytomegalovirus-specific igm in human sera by enzyme immunoassay
07/13/2006WO2006074451A2 Targeted chimeric molecules for cancer therapy
07/13/2006WO2006074389A2 Four-helical bundle protein zsig99
07/13/2006WO2006074199A1 Immunoglobulin chimeric monomer-dimer hybrids
07/13/2006WO2006072845A2 Gram positive bacterial cells comprising a disrupted flagellin gene, flagellin-based fusion proteins and use in removal of metal ions from a liquid
07/13/2006WO2006072620A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
07/13/2006WO2006072202A1 A rantes-dt390 recombinant immunotoxin plasmid targeting activated th1 cells and production method and uses thereof
07/13/2006WO2006006954A3 Modified fusion peptides derived from a p53 domain against malignant and/or transformed mammalian cells
07/13/2006WO2005069845A3 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
07/13/2006US20060155115 Multivalent T cell receptor complexes
07/13/2006US20060154854 Molecules for targeting and releasing therapeutic compounds, and the use thereof
07/13/2006US20060154339 Novel clock gene BMAL2
07/13/2006US20060154307 Receptor assay
07/13/2006US20060154294 Interleukin-18 binding proteins, their preparation and use
07/13/2006US20060154244 Novel g-protein coupled receptor
07/13/2006US20060153866 Human immunodeficiency virus-1 group O/M envelope polypeptide fusion for use as evaluative tool in diagnosing viral infection
07/13/2006US20060153864 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein.
07/13/2006US20060153836 Using monoclonal antibody specific for kidney injury-molecule-1 (KIM-1) to diagnose, prevent and treat cell proliferative and kidney disorders; immunotherapeutics
07/13/2006US20060153802 Mammalian chemokine reagents
07/13/2006CA2594356A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
07/13/2006CA2594023A1 Igf-i fusion polypeptides and therapeutic uses thereof
07/13/2006CA2588871A1 Gram positive bacterial cells comprising a disrupted flagellin gene, flagellin-based fusion proteins and use in removal of metal ions from a liquid
07/12/2006EP1679373A2 Lipase and use of same for improving doughs and baked products
07/12/2006EP1625161A4 A synthetic bioelastomer
07/12/2006EP1470158B1 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
07/12/2006EP1196583B1 Type ii dna polymerase from pyrococcus abyssi
07/12/2006CN1800402A Infusion protein of single chain antibodyA1 and metacide hydrolase, and its preparation method
07/12/2006CN1800385A Hybrid expression of neisserial proteins
07/12/2006CN1800376A Recombinant T4 phage for displaying influenza virus non-structural protein NS1 and its uses
07/12/2006CN1800218A Fusion protein of tumour new-born blood vessel-specific bonding polypeptide and recombinant human Tum-5, and its preparation method
07/12/2006CN1800214A Human receptor proteinsíórelated reagents and methods
07/12/2006CN1263852C Extracellular matrix signalling molecules
07/12/2006CN1263771C Preparing method and use for osteoprotegerin fusion protein
07/12/2006CN1263507C APRIL receptor (BCMA) and uses thereof
07/11/2006US7074905 An empty sc-MHC class II molecule comprising a peptide binding groove and a class II beta 2 chain comprising at least one amino acid substitution or deletion; immunosuppressants